Task: Answer the multiple-choice question.
Query: Which compound exhibits a 21.112% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) CCn1c(SCC(=O)NC2CCCC2)nnc1C(C)NC(=O)c1ccccc1Br
b.) CC(C)CNc1nc(N)c([N+](=O)[O-])c(NCC2CCCO2)n1
c.) CCOC(=O)COc1cc(=O)n(CC)c2ccccc12
Answer: a. CCn1c(SCC(=O)NC2CCCC2)nnc1C(C)NC(=O)c1ccccc1Br
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1c(SCC(=O)NC2CCCC2)nnc1C(C)NC(=O)c1ccccc1Br
CCn1c(SCC(=O)NC2CCCC2)nnc1C(C)NC(=O)c1ccccc1Br
2-bromo-N-[1-[5-[2-(cyclopentylamino)-2-oxoethyl]sulfanyl-4-ethyl-1,2,4-triazol-3-yl]ethyl]benzamide